An open label trial of ziprasidone as an adjuvant for clozapine- or olanzapine-associated diabetes mellitus or impaired fasting glucose in chronic schizophrenia
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2013
At a glance
- Drugs Ziprasidone (Primary) ; Clozapine; Olanzapine
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- 20 Nov 2006 New trial record.